(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure...
Stats | |
---|---|
Dagens volum | 435 741 |
Gjennomsnittsvolum | 433 463 |
Markedsverdi | 10.98B |
EPS | €0 ( 2024-02-19 ) |
Neste inntjeningsdato | ( €0.550 ) 2024-05-06 |
Last Dividend | €1.120 ( 2023-05-17 ) |
Next Dividend | €0 ( N/A ) |
P/E | 22.01 |
ATR14 | €0.0210 (0.06%) |
Volum Korrelasjon
Fresenius Medical Care AG Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Fresenius Medical Care AG Korrelasjon - Valuta/Råvare
Fresenius Medical Care AG Økonomi
Annual | 2023 |
Omsetning: | €19.45B |
Bruttogevinst: | €4.93B (25.32 %) |
EPS: | €1.700 |
FY | 2023 |
Omsetning: | €19.45B |
Bruttogevinst: | €4.93B (25.32 %) |
EPS: | €1.700 |
FY | 2022 |
Omsetning: | €19.40B |
Bruttogevinst: | €5.31B (27.37 %) |
EPS: | €2.30 |
FY | 2021 |
Omsetning: | €17.62B |
Bruttogevinst: | €5.08B (28.82 %) |
EPS: | €3.30 |
Financial Reports:
No articles found.
Fresenius Medical Care AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€1.120 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.230 | 2000-05-31 |
Last Dividend | €1.120 | 2023-05-17 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 26 | -- |
Total Paid Out | €18.29 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.16 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.95 | |
Div. Directional Score | 8.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OEWA.DE | Ex Dividend Knight | 2023-05-02 | Annually | 0 | 0.00% | |
ALD.DE | Ex Dividend Knight | 2023-08-10 | Quarterly | 0 | 0.00% | |
HAG.DE | Ex Dividend Junior | 2023-05-15 | Annually | 0 | 0.00% | |
RHK.DE | Ex Dividend Junior | 2023-06-09 | Sporadic | 0 | 0.00% | |
BSL.DE | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
IXX.DE | Ex Dividend Knight | 2023-05-26 | Annually | 0 | 0.00% | |
SZG.DE | Ex Dividend Junior | 2023-05-26 | Annually | 0 | 0.00% | |
DBK.DE | Ex Dividend Junior | 2023-05-18 | Sporadic | 0 | 0.00% | |
MBG.DE | Ex Dividend Knight | 2023-05-04 | Annually | 0 | 0.00% | |
47T.F | Ex Dividend Knight | 2023-09-06 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0281 | 1.500 | 9.44 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0161 | 1.200 | 9.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0398 | 1.500 | -0.669 | -1.004 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.424 | 0.800 | 7.88 | 6.30 | [1 - 3] |
quickRatioTTM | 0.916 | 0.800 | 9.32 | 7.45 | [0.8 - 2.5] |
cashRatioTTM | 0.230 | 1.500 | 9.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.355 | -1.500 | 4.08 | -6.12 | [0 - 0.6] |
interestCoverageTTM | 3.47 | 1.000 | 9.83 | 9.83 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.96 | 2.00 | 7.01 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 6.63 | 2.00 | 6.69 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.885 | -1.500 | 6.46 | -9.69 | [0 - 2.5] |
grossProfitMarginTTM | 0.253 | 1.000 | 9.11 | 9.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0710 | 1.000 | -0.580 | -0.580 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.218 | 1.000 | 9.90 | 9.90 | [0.2 - 2] |
assetTurnoverTTM | 0.573 | 0.800 | 9.51 | 7.61 | [0.5 - 2] |
Total Score | 11.04 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 20.09 | 1.000 | 8.07 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0398 | 2.50 | -0.430 | -1.004 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 6.63 | 2.00 | 7.79 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.99 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.96 | 2.00 | 7.01 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.662 | 1.500 | 2.25 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.135 | 1.000 | 9.12 | 0 | [0.1 - 0.5] |
Total Score | 4.95 |
Fresenius Medical Care AG
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.